Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Trial details
- Registry ID
- NCT04445987
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic DermatitisNCT04445987 | ARQT | Phase 2 | Completed | 2022-11-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |